Sponsor:
Sierra Eye Associates
Code:
NCT06942520
Conditions
Diabetic Macular Edema
Eligibility Criteria
Sex: All
Age: 25 - 70+
Healthy Volunteers: Not accepted
Interventions
RGX-314 Dose 1
RGX-314 Dose 2
Aflibercept (2.0 mg)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-27. This information was provided to ClinicalTrials.gov by Sierra Eye Associates on 2025-04-24.